Latest Content

Eating disorders pose a significant risk to athletes' health, highlighting the urgent need for awareness, support, and compassionate change in sports culture.

Researchers discuss precision medicine's potential to enhance opioid use disorder treatment.

Reflecting on Martin Luther King Jr.'s legacy, the article explores his insights on mental health, social justice, and the need for unity today.

Review the misperceptions patients and clinicians may have about ADHD diagnosis and treatment.

Experts discuss the complex relationship between ADHD treatment and substance use disorder.

Barry Herman, MD, shares insights on real-world data of online ADHD assessment tool and telepsychiatry.

Clinicians explore the complex relationship between ADHD medication and pregnancy, emphasizing individualized risk assessments for optimal maternal and child health.

A groundbreaking online ADHD assessment shows 78% agreement with clinician evaluations, enhancing access to mental health care for adults.

Seltorexant shows promise as a safe adjunctive treatment for patients with major depressive disorder and insomnia symptoms, with fewer weight changes than quetiapine XR.

Explore the emerging role of lifestyle interventions in psychiatry, enhancing patient care through nutrition and physical activity for mental health.

New research reveals midlife ADHD patients exhibit early Alzheimer disease biomarkers.

New data reveals Caplyta significantly improves remission rates in adults with major depressive disorder, offering hope for lasting relief from symptoms.

Centanafadine demonstrates promising effects on ADHD symptoms, enhancing key neurotransmitters without increasing psychomotor activity, according to poster data.